Literature DB >> 12065518

Complement activation and formation of the membrane attack complex on serogroup B Neisseria meningitidis in the presence or absence of serum bactericidal activity.

M Drogari-Apiranthitou1, E J Kuijper, N Dekker, J Dankert.   

Abstract

Encapsulated meningococci are complement sensitive only in the presence of bactericidal antibodies by yet-unexplored mechanisms. The objective of this study was to investigate the involvement of major bacterial surface constituents on complement activation and membrane attack complex (MAC) formation on serogroup B meningococci in the presence or absence of antibody-dependent serum bactericidal activity (SBA). The strains used were the encapsulated H44/76, five of its variants differing in capsulation and expression of the class 1 porin (PorA), and its lipopolysaccharide (LPS)-deficient isogenic mutant (LPS(-)) pLAK33. Two normal sera, one with high SBA (SBA(+)) and one with no bactericidal activity (SBA(-)) against H44/76 as well as an a-gamma-globulinemic serum were used for sensibilization of the bacteria. C3b and iC3b deposition on H44/76, its unencapsulated variant v24, and pLAK33 was similar in SBA(+) and SBA(-) serum, and no difference was present between the strains. MAC deposition on H44/76 was higher in SBA(+) serum than in SBA(-) serum and the a-gamma-globulinemic serum. The amounts of C3b on H44/76, v24, and pLAK33 in the a-gamma-globulinemic serum were also not different, indicating immunoglobulin G (IgG)- and LPS-independent complement activation. H44/76 PorA(+) and its PorA(-) variant and the v24 PorA(+) and its PorA(-) variant incubated in SBA(-) serum induced comparable amounts of MAC, despite their different serum sensitivities. Complement formation on the surface of the bacteria occurred almost exclusively via the classical pathway, but the considerable amounts of Bb measured in the serum indicated alternative pathway activation in the fluid phase. We conclude that complement deposition on meningococci is, for the most part, independent of classical pathway IgG and is not influenced by the presence of PorA or LPS on the meningococcal surface. Addition of an anti-PorA chimeric antibody to the nonbactericidal normal serum, while promoting a dose-related bacterial lysis, did not influence the amounts of C3b, iC3b, and MAC formed on the bacterial surface. These findings support the hypothesis that proper MAC insertion rather than the quantity of MAC formed on the bacterial surface is of importance for efficient lysis of meningococci.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12065518      PMCID: PMC128098          DOI: 10.1128/IAI.70.7.3752-3758.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

Review 1.  Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes.

Authors:  C E Frasch; W D Zollinger; J T Poolman
Journal:  Rev Infect Dis       Date:  1985 Jul-Aug

2.  Antibody-independent killing of gram-negative bacteria via the classical pathway of complement.

Authors:  M Loos; F Clas
Journal:  Immunol Lett       Date:  1987-02       Impact factor: 3.685

Review 3.  Functions and relevance of the terminal complement sequence.

Authors:  S Bhakdi; F Hugo; J Tranum-Jensen
Journal:  Blut       Date:  1990-06

4.  Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes.

Authors:  S Bhakdi; R Käflein; T S Halstensen; F Hugo; K T Preissner; T E Mollnes
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

Review 5.  Damage to mammalian cells by proteins that form transmembrane pores.

Authors:  S Bhakdi; J Tranum-Jensen
Journal:  Rev Physiol Biochem Pharmacol       Date:  1987       Impact factor: 5.545

Review 6.  Ba and Bb fragments of factor B activation: fragment production, biological activities, neoepitope expression and quantitation in clinical samples.

Authors:  W P Kolb; P R Morrow; J D Tamerius
Journal:  Complement Inflamm       Date:  1989

Review 7.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

8.  Analysis of C3 deposition and degradation on bacterial surfaces after opsonization.

Authors:  D L Gordon; J Rice; J J Finlay-Jones; P J McDonald; M K Hostetter
Journal:  J Infect Dis       Date:  1988-04       Impact factor: 5.226

9.  The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica.

Authors:  K A Cartwright; J M Stuart; D M Jones; N D Noah
Journal:  Epidemiol Infect       Date:  1987-12       Impact factor: 2.451

10.  Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium.

Authors:  K A Joiner; A B Tartanian; C H Hammer; J E Schweinle
Journal:  J Immunol       Date:  1989-06-15       Impact factor: 5.422

View more
  16 in total

Review 1.  The role of the complement system in innate immunity.

Authors:  Horea Rus; Cornelia Cudrici; Florin Niculescu
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 2.  Sepsis, apoptosis and complement.

Authors:  P A Ward
Journal:  Biochem Pharmacol       Date:  2008-09-20       Impact factor: 5.858

3.  Functional characterization of exopolyphosphatase/guanosine pentaphosphate phosphohydrolase (PPX/GPPA) of Campylobacter jejuni.

Authors:  Anandkumar Malde; Dharanesh Gangaiah; Kshipra Chandrashekhar; Ruby Pina-Mimbela; Jordi B Torrelles; Gireesh Rajashekara
Journal:  Virulence       Date:  2014-02-25       Impact factor: 5.882

Review 4.  Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology.

Authors:  Masashi Mizuno; Yasuhiro Suzuki; Yasuhiko Ito
Journal:  Clin Exp Nephrol       Date:  2017-03-24       Impact factor: 2.801

5.  The role of the exopolyphosphatase PPX in avoidance by Neisseria meningitidis of complement-mediated killing.

Authors:  Qian Zhang; Yanwen Li; Christoph M Tang
Journal:  J Biol Chem       Date:  2010-08-24       Impact factor: 5.157

6.  The sensitivity of escherichia coli strains with K1 surface antigen and rods without this antigen to the bactericidal effect of serum.

Authors:  A Cisowska; S Jankowski
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

7.  Pre-neutralization of C5a-mediated effects by the monoclonal antibody 137-26 reacting with the C5a moiety of native C5 without preventing C5 cleavage.

Authors:  M Fung; M Lu; H Fure; W Sun; C Sun; N Y Shi; Y Dou; J Su; X Swanson; T E Mollnes
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

8.  Hepatitis C virus suppresses C9 complement synthesis and impairs membrane attack complex function.

Authors:  Hangeun Kim; Keith Meyer; Adrian M Di Bisceglie; Ranjit Ray
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

9.  Serum bactericidal activity against Helicobacter pylori in patients with hypogammaglobulinaemia.

Authors:  I M E Desar; M van Deuren; T Sprong; J B M J Jansen; F Namavar; C M Vandenbroucke-Grauls; J W M van der Meer
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

10.  A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies.

Authors:  Maria Jose Uria; Qian Zhang; Yanwen Li; Angel Chan; Rachel M Exley; Bridget Gollan; Hannah Chan; Ian Feavers; Andy Yarwood; Raquel Abad; Ray Borrow; Roland A Fleck; Barbara Mulloy; Julio A Vazquez; Christoph M Tang
Journal:  J Exp Med       Date:  2008-05-26       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.